Moody’s also affirmed the “A2” rating on the health system’s outstanding bonds.
The ratings affirmations are based on several factors, including the health system’s solid and leading market share position and solid leverage metrics.
The outlook was revised from stable to negative, reflecting Moody’s Investors Service’s unfavorable opinion of the health system’s multiyear trend of challenged operating performance through fiscal year 2017.
More articles on healthcare finance:
AMGA joins provider groups urging CMS to include Medicare Advantage in advanced APM models
Lifespan grows operating income in Q2 as expenses climb
RCM tip of the day: Use data to drive smarter payment plans
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.